Zobrazeno 1 - 10
of 383
pro vyhledávání: '"D. Ruff"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Suresh Sabbenahalli, Elyse M. Cornett, Dustin R. Latimer, Kayla M. Penny, Rachel D. Ruff, Shaan B. Patel, Alan D. Kaye, Kelsey C. Rooney, Amber N. Edinoff, Omar Viswanath, Ivan Urits, Adam M. Kaye
Publikováno v:
Neurology International
Neurology International, Vol 13, Iss 26, Pp 252-265 (2021)
Neurology International, Vol 13, Iss 26, Pp 252-265 (2021)
Medical management of epilepsy seeks to eliminate or to reduce the frequency of seizures, help patients maintain a normal lifestyle, and maintain psychosocial and occupational activities, while avoiding the negative side effects of long-term treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8c7abd8e0e616426bf80d881dc81126
https://doi.org/10.3390/neurolint13020026
https://doi.org/10.3390/neurolint13020026
Autor:
Mallikarjuna Rettiganti, Martha D. Port, Janet H. Ford, David W. Ayer, Tobias Kurth, Linda Wietecha, Amaal J. Starling, Dustin D. Ruff
Publikováno v:
Headache
Objective This post hoc study investigated the relationship between patient response in terms of migraine headache day reduction and patient‐reported outcomes of health‐related quality of life (HRQoL) and disability categories. Background Migrain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e6c9e76eefa34edc6fc472fbd37bc5b
https://doi.org/10.1111/head.14013
https://doi.org/10.1111/head.14013
Autor:
Edward S. Kolesar, Matthew D. Ruff
Publikováno v:
2003 GSW Proceedings.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9c79b28198d875300219a2d4649f0e6
https://doi.org/10.18260/1-2-620-38510
https://doi.org/10.18260/1-2-620-38510
Autor:
John H. Krege, Sherie A. Dowsett, Todd J. Schwedt, P A Ardayfio, Sonja M. Bragg, Erin G Doty, Cristina Tassorelli, Dustin D. Ruff
Publikováno v:
The Journal of Headache and Pain
The Journal of Headache and Pain, Vol 22, Iss 1, Pp 1-8 (2021)
The Journal of Headache and Pain, Vol 22, Iss 1, Pp 1-8 (2021)
Background Lasmiditan (LTN) is a selective 5-HT1F receptor agonist for the acute treatment of migraine in adults. We present detailed safety findings from the placebo-controlled, double-blind Phase 3 study, of LTN treatment across 4 attacks (CENTURIO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4895543a4e2db623beed5bfdc3c5b544
http://europepmc.org/articles/PMC8572440
http://europepmc.org/articles/PMC8572440
Autor:
Sheena K. Aurora, Yan Dong, Virginia L. Stauffer, Jakub Jedynak, David W. Dodick, Dustin D. Ruff, Eric M. Pearlman, Erin G Doty
Publikováno v:
Cephalalgia : an international journal of headache. 41(3)
Introduction Acute medication overuse is prevalent in patients with migraine. Methods In three phase 3, double-blind, randomized, placebo-controlled studies, patients with episodic migraine (EVOLVE-1 and EVOLVE-2) or chronic migraine (REGAIN) were ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c9be721a4752547174e6b5341770e26
https://pubmed.ncbi.nlm.nih.gov/33143451
https://pubmed.ncbi.nlm.nih.gov/33143451
Autor:
Antje Tockhorn-Heidenreich, Sriram Govindan, Janet H. Ford, Peter J. Goadsby, Dustin D. Ruff, Virginia L. Stauffer, Sheena K. Aurora, Gisela M Terwindt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b139fc1facd022c0fe3295c64457612d
http://hdl.handle.net/1887/3182717
http://hdl.handle.net/1887/3182717
Autor:
Li Shen Loo, Andrew S. Buchanan, Louise Lombard, Dustin D. Ruff, Dawn C. Buse, Richard B. Lipton, John H. Krege, Thomas E. Melby
Publikováno v:
The Journal of Headache and Pain
The Journal of Headache and Pain, Vol 21, Iss 1, Pp 1-15 (2020)
The Journal of Headache and Pain, Vol 21, Iss 1, Pp 1-15 (2020)
Background Migraine is recognized as the second leading cause of disability globally. Lasmiditan is a novel, selective serotonin 5-HT1F receptor agonist developed for acute treatment of migraine. Here we analyzed effects of lasmiditan on migraine dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e298e5c43010221f50ea1d6522750cae
http://europepmc.org/articles/PMC7041198
http://europepmc.org/articles/PMC7041198
Autor:
Eric M. Pearlman, Sheena K. Aurora, Erin G Doty, Sara Sacco, Dustin D. Ruff, Russell M Nichols
Publikováno v:
Headache
Objective To examine the likelihood of response with continued galcanezumab treatment in patients with episodic or chronic migraine without initial clinical improvement. Background A percentage of patients with migraine may require additional time on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cfcdd465bd1b77a43baf3209b3f9a0d
https://doi.org/10.1111/head.13443
https://doi.org/10.1111/head.13443
Publikováno v:
Headache
Objective To characterize adult patients with episodic migraine who achieved 100% response to galcanezumab treatment. Background Galcanezumab is a humanized monoclonal antibody that selectively binds to the calcitonin gene‐related peptide (CGRP) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c4a0af7384a8c6f3bfdcd569c811bcf
https://doi.org/10.1111/head.13427
https://doi.org/10.1111/head.13427